Literature DB >> 9264396

Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity.

N Hoogerbrugge, H Jansen, P M Hoogerbrugge.   

Abstract

A 13-year-old girl with acute lymphoblastic leukemia (ALL) developed extremely high plasma triglyceride (TG) concentrations of 103 mmol/l (reference value <1.8 mmol/l) during combination treatment with corticosteroids and asparaginase. Corticosteroids are known to induce the production of TG-rich particles. On the other hand, corticosteroids increase the activity of lipoprotein lipase (LPL), a key enzyme in the removal of TG from plasma. Generally, the increased LPL activity prevents an extreme rise in TG levels upon therapy with corticosteroids. In our patient, we found that the corticosteroid-induced LPL activity dramatically declined after therapy with L-asparaginase. This suggests that the extensive hypertriglyceridemia in our patient was due to an L-asparaginase-induced decrease in LPL activity. This hypothesis was further supported by the finding that hypertriglyceridemia was less severe when corticosteroids and asparaginase were given separately.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264396     DOI: 10.1038/sj.leu.2400703

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  11 in total

1.  The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.

Authors:  Wing H Tong; Rob Pieters; Hester A de Groot-Kruseman; Wim C J Hop; Joachim Boos; Wim J E Tissing; Inge M van der Sluis
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

2.  Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.

Authors:  Emily R Finch; Colton A Smith; Wenjian Yang; Yiwei Liu; Nancy M Kornegay; John C Panetta; Kristine R Crews; Alejandro R Molinelli; Cheng Cheng; Deqing Pei; Laura B Ramsey; Seth E Karol; Hiroto Inaba; John T Sandlund; Monika Metzger; William E Evans; Sima Jeha; Ching-Hon Pui; Mary V Relling
Journal:  Pediatr Blood Cancer       Date:  2019-10-14       Impact factor: 3.167

3.  Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia.

Authors:  Rajesh R Nair; Werner J Geldenhuys; Debbie Piktel; Prabodh Sadana; Laura F Gibson
Journal:  Bioorg Med Chem Lett       Date:  2018-03-23       Impact factor: 2.823

4.  Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?

Authors:  Harsha Prasada Lashkari; Donna Lancaster; Ayad Atra; Michael P Champion; Mary M Taj
Journal:  Int J Hematol       Date:  2011-11-08       Impact factor: 2.490

5.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger
Journal:  Eur J Cancer       Date:  2014-07-30       Impact factor: 9.162

6.  Asparaginase-Induced Hypertriglyceridemia Presenting as Pseudohyponatremia during Leukemia Treatment.

Authors:  Ashley Hinson; Dorothee Newbern; Corinne M Linardic
Journal:  Case Rep Pediatr       Date:  2014-10-27

Review 7.  Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Authors:  Kjeld Schmiegelow; Klaus Müller; Signe Sloth Mogensen; Pernille Rudebeck Mogensen; Benjamin Ole Wolthers; Ulrik Kristoffer Stoltze; Ruta Tuckuviene; Thomas Frandsen
Journal:  F1000Res       Date:  2017-04-07

8.  Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.

Authors:  Pernille Rudebeck Mogensen; Kathrine Grell; Kjeld Schmiegelow; Ulrik Malthe Overgaard; Benjamin Ole Wolthers; Signe Sloth Mogensen; Allan Vaag; Thomas Leth Frandsen
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

9.  Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia.

Authors:  Arcangelo Iannuzzi; Mario Annunziata; Giuliana Fortunato; Carola Giacobbe; Daniela Palma; Alessandro Bresciani; Emilio Aliberti; Gabriella Iannuzzo
Journal:  Front Genet       Date:  2022-02-14       Impact factor: 4.599

Review 10.  A Comprehensive Update on the Chylomicronemia Syndrome.

Authors:  Ronald B Goldberg; Alan Chait
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.